ARCHIVES

Going private may allow US Oncology to restructure, respond to Medicare cuts; equity investment firm offers to purchase shares.

This article is from The Cancer Letter archive.

Vol. 30 No. 17 | April 23, 2004

Download PDF Visit The Full Archive

Related Articles

FDA: Silicone Breast Implants Safe, But Not “Lifetime Device”

June 24, 2011

Lippman Named UCSD Cancer Center Director

May 4, 2012

NCI Fund Grants To Increase Minority Internet Access.

October 6, 2000

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999

The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year

April 20, 2012

Three-Quarters of P01 $$ Goes To Translational Grants, NCI Finds

October 2, 1992